Overexpression of BDNF and TrkB in human bladder cancer specimens

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1265-1270

  Lai, Pei Chun ^a,b   Chiu, Ted H ^a,b   Huang, Yen T A ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Bladder cancer; Brain derived neurotrophic factor; Immunohistochemistry; Transitional cell carcinoma; Tropomyosin receptor kinase B

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; PARAFFIN;

ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DISEASE SEVERITY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCORING SYSTEM; SUPERFICIAL CANCER; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CARCINOMA, TRANSITIONAL CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; RECEPTOR, TRKB; URINARY BLADDER NEOPLASMS;

EID: 78049491063     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000981     Document Type: Article

References (32)

1. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX and Malats N: Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 25: 285-295, 2007.
2. Hayat MJ, Howlader N, Reichman ME and Edwards BK: Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12: 20-37, 2007.
3. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettlin C and Menck HR: The national cancer data base report on bladder carcinoma. The american college of surgeons commission on cancer and the american cancer society. Cancer 78: 1505-1513, 1996.
4. Tavora F and Epstein JI: Bladder cancer, pathological classification and staging. BJU Int 102: 1216-1220, 2008.
5. Ramos Soler D, Ferrer Lozano J, Navarro Fos S and Llombart-Bosch A: Multiple analysis of morphologic factors with prognostic value in transitional cell papillary carcinoma of the bladder. Retrospective study of 571 cases. Actas Urol Esp 23: 119-126, 1999.
6. Hall MC, Chang SS, Dalbagni G, et al: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178: 2314-2330, 2007.
7. Stenzl A, Cowan NC, De Santis M, et al: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 55: 815-825, 2009.
8. Sonpavde G and Sternberg CN: Treatment of metastatic urothelial cancer: Opportunities for drug discovery and development. BJU Int 102: 1354-1360, 2008.
9. Shah JB and McKiernan JM: Novel therapeutics in the treatment of bladder cancer. Curr Opin Urol 14: 287-293, 2004.
10. Huang EJ and Reichardt LF: Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24: 677-736, 2001.
11. Shibayama E and Koizumi H: Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 148: 1807-1818, 1996.
12. Murray E, Malley SE, Qiao LY, Hu VY and Vizzard MA: Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J Urol 172: 2434-2439, 2004.
13. Lommatzsch M, Braun A, Mannsfeldt A, et al: Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. Am J Pathol 155: 1183-1193, 1999.
14. Ho R, Eggert A, Hishiki T, et al: Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 62: 6462-6466, 2002.
15. Jaboin J, Hong A, Kim CJ and Thiele CJ: Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma. Cancer Lett 193: 109-114, 2003.
16. Jaboin J, Kim CJ, Kaplan DR and Thiele CJ: Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res 62: 6756-6763, 2002.
17. Miknyoczki SJ, Lang D, Huang L, Klein-Szanto AJ, Dionne CA and Ruggeri BA: Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects on in vitro invasive behavior. Int J Cancer 81: 417-427, 1999.
18. Montano X and Djamgoz MB: Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Lett 571: 1-8, 2004.
19. Ricci A, Greco S, Mariotta S, et al: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 25: 439-446, 2001.
20. Yang ZF, Ho DW, Lam CT, et al: Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 65: 219-225, 2005.
21. Pearse RN, Swendeman SL, Li Y, Rafii D and Hempstead BL: A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105: 4429-4436, 2005.
22. Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC, Lan YF and Chiu TH: BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells. Int J Oncol 36: 1469-1476, 2010.
23. Tsuruta H, Kishimoto H, Sasaki T, et al: Hyperplasia and carcinomas in PTEN-deficient mice and reduced PTEN protein in human bladder cancer patients. Cancer Res 66: 8389-8396, 2006.
24. Robinson DR, Wu YM and Lin SF: The protein tyrosine kinase family of the human genome. Oncogene 19: 5548-5557, 2000.
25. Pusztai L, Lewis CE, Lorenzen J and McGee JO: Growth factors: Regulation of normal and neoplastic growth. J Pathol 169: 191-201, 1993.
26. Krause DS and Van Etten RA: Tyrosine kinases as targets for cancer therapy. N Engl J Med 353: 172-187, 2005.
27. Black PC, Agarwal PK and Dinney CP: Targeted therapies in bladder cancer - an update. Urol Oncol 25: 433-438, 2007.
28. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E and Peeper DS: Suppression of anoikis and induction of metastasis by the neurotrophic receptor trkb. Nature 430: 1034-1039, 2004.
29. Yu X, Liu L, Cai B, He Y and Wan X: Suppression of anoikis by the neurotrophic receptor trkb in human ovarian cancer. Cancer Sci 99: 543-552, 2008.
30. Subramanian H, Roy HK, Pradhan P, et al: Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res 69: 5357-5363, 2009.
31. Kakizoe T, Tobisu K, Tanaka Y, Mizutani T, Teshima SC, Kishi K and Tsutsumi M: Development of multiple transitional cell carcinomas in the urinary tract. Jpn J Clin Oncol 21: 110-114, 1991.
32. Stoehr R, Knuechel R, Boecker J, et al: Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones. Lab Invest 82: 1553-1561, 2002.